Skip to main content
Log in

Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Oxytocin (OT), vasopressin (AVP) and 3,4 methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) all increase social interaction in rats, perhaps by enhancing the rewarding value of social encounters.

Objectives

Here, we used the conditioned place preference (CPP) paradigm to assess the intrinsic rewarding effects of OT, AVP and MDMA, and whether these effects are enhanced by the presence of a conspecific, or a dynamic, tactile object (a tennis ball).

Methods

Adult male rats received conditioning sessions in a CPP apparatus twice a day (vehicle at 10 a.m., drug at 3 p.m.). Experiment 1 involved conditioning with OT (0.5 mg/kg, intraperitoneal (i.p.)), AVP (0.005 mg/kg, i.p.) or MDMA (5 mg/kg, i.p.). Experiments 2 and 3 involved conditioning with the same treatments but in the presence of a conspecific receiving the same treatment (social-CPP) or in the presence of a tennis ball (object-CPP), respectively. Conditioned place preference was assessed 24 h, 2 weeks and 4 weeks later.

Results

OT, AVP and MDMA did not produce a conventional CPP. However, when the conditioning environment also contained a conspecific both OT and MDMA induced a significant CPP lasting for at least 4 weeks. Rats given OT and MDMA also developed a more modest yet significant CPP for the environment where they encountered a tennis ball.

Conclusions

These results indicate that OT and MDMA can augment the rewarding effects of social interaction, but also interaction with a dynamic and tactile non-social object. AVP does not condition social- or object-CPPs and may promote social proximity by inducing generalized anxiety and defensive aggregation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Aguilar MA, Rodriguez-Arias M, Minarro J (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 59:253–277

    Article  PubMed  Google Scholar 

  • Baracz SJ, Rourke PI, Pardey MC, Hunt GE, McGregor IS, Cornish JL (2012) Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behav Brain Res 228:185–193

    Article  CAS  PubMed  Google Scholar 

  • Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bethlehem RA, Baron-Cohen S, van Honk J, Auyeung B, Bos PA (2014) The oxytocin paradox. Front Behav Neurosci 8:48

    Article  PubMed Central  PubMed  Google Scholar 

  • Beurel E, Nemeroff CB (2014) Interaction of stress, corticotropin-releasing factor, arginine vasopressin and behaviour. Curr Top Behav Neurosci 18:67–80

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc 1:1306–1311

    Article  PubMed  Google Scholar 

  • Bielsky IF, Young LJ (2004) Oxytocin, vasopressin, and social recognition in mammals. Peptides 25:1565–1574

    Article  CAS  PubMed  Google Scholar 

  • Bielsky IF, Hu S, Ren X, Terwilliger EF, Young LJ (2005) The V1a Vasopressin Receptor Is Necessary and Sufficient for Normal Social Recognition: A Gene Replacement Study. Neuron 47:503–513.

  • Bilsky EJ, Montegut MJ, Nichols ML, Reid LD (1998) CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol Biochem Behav 59:215–220

    Article  CAS  PubMed  Google Scholar 

  • Bowen MT, McGregor IS (2014) Oxytocin and vasopressin modulate the social response to threat: a preclinical study. Int J Neuropsychopharmacol 17:1621–1633

    Article  CAS  PubMed  Google Scholar 

  • Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS (2011) Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS ONE 6:e27237

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brielmaier JM, McDonald CG, Smith RF (2008) Nicotine place preference in a biased conditioned place preference design. Pharmacol Biochem Behav 89:94–100

    Article  CAS  PubMed  Google Scholar 

  • Cornish JL, Shahnawaz Z, Thompson MR, Wong S, Morley KC, Hunt GE, McGregor IS (2003) Heat increases 3, 4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol 482:339–341

    Article  CAS  PubMed  Google Scholar 

  • Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987) Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology 91: 363–368

  • Dantzer R, Koob GF, Le Moal M (1988) Septal vasopressin modulates social memory in male rats. Brain Res 457:143–147

    Article  CAS  PubMed  Google Scholar 

  • Dolen G, Darvishzadeh A, Huang KW, Malenka RC (2013) Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501:179–18

  • Domes G, Sibold M, Schulze L, Lischke A, Herpertz S, Heinrichs M (2012) Intranasal oxytocin increases covert attention to positive social cues. Psychol Med 12:1–8

    Google Scholar 

  • Douglas LA, Varlinskaya EI, Spear LP (2004) Rewarding properties of social interactions in adolescent and adult male and female rats: impact of social versus isolate housing of subjects and partners. Dev Psychobiol 45:153–162

    Article  PubMed  Google Scholar 

  • Egashira N, Tanoue A, Matsuda T, Koushi E, Harada S, Takano Y, Tsujimoto G, Mishima K, Iwasaki K, Fujiwara M (2007) Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav Brain Res 178:123–127

    Article  CAS  PubMed  Google Scholar 

  • Ettenberg A, Van Der Kooy D, Le Moal M, Koob GF, Bloom FE (1983) Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? Behav Brain Res 7:331–350

    Article  CAS  PubMed  Google Scholar 

  • Frye CG, Wardle MC, Norman GJ, de Wit H (2014) MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav 117:1–6

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol Rev 55:463–508

    Article  CAS  PubMed  Google Scholar 

  • Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand J-P, Soubrié P (2002) Anxiolytic-and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders. Proc Natl Acad Sci U S A 99:6370–6375

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L, Grunder G, Spreckelmeyer KN (2013) Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol Psychiatry 74:172–179

    Article  CAS  PubMed  Google Scholar 

  • Harris G (2004) What all social workers should know about MDMA (Ecstasy). J Soc Work Pract Addict 4:23–37

    Article  Google Scholar 

  • Heinrichs M, von Dawans B, Domes G (2009) Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 30:548–557

    Article  CAS  PubMed  Google Scholar 

  • Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M (1998) Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet 351:1784

  • Herzig V, Capuani E, Kovar KA, Schmidt W (2005) Effects of MPEP on expression of food‚ MDMA amphetamine conditioned place preference in rats. Addict Biol 10:243–249

    Article  CAS  PubMed  Google Scholar 

  • Hicks C, Ramos L, Reekie T, Misagh G, Narlawar R, Kassiou M, McGregor I (2014) Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br J Pharmacol 171:2868–2887

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hunt GE, McGregor IS, Cornish JL, Callaghan PD (2011) MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Res Bull 86:65–73

    Article  CAS  PubMed  Google Scholar 

  • Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25:11489–11493

    Article  CAS  PubMed  Google Scholar 

  • Liberzon I, Trujillo KA, Akil H, Young EA (1997) Motivational properties of oxytocin in the conditioned place preference paradigm. Neuropsychopharmacology 17:353–359

    Article  CAS  PubMed  Google Scholar 

  • Lukas M, Neumann ID (2012) Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav Brain Res 251:85–94

    Article  PubMed  Google Scholar 

  • Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID (2011) The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 36:2159–2168

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • MacDonald K, Feifel D (2012) Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatr 24:130–146

    Article  PubMed Central  PubMed  Google Scholar 

  • Madularu D, Athanassiou M, Yee JR, Mumby DG (2014) Centrally-administered oxytocin promotes preference for familiar objects at a short delay in ovariectomized female rats. Behav Brain Res 274:164–167

    Article  CAS  PubMed  Google Scholar 

  • Mak P, Broussard C, Vacy K, Broadbear JH (2012) Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat. J Psychopharmacol 26:532–542

    Article  CAS  PubMed  Google Scholar 

  • Marshall AD (2013) Posttraumatic stress disorder and partner-specific social cognition: a pilot study of sex differences in the impact of arginine vasopressin. Biol Psychol 93:296–303

    Article  PubMed Central  PubMed  Google Scholar 

  • Meyer A, Mayerhofer A, Kovar K-A, Schmidt WJ (2002) Rewarding effects of the optical isomers of 3, 4-methylenedioxy-methylamphetamine (Ecstasy) and 3, 4-methylenedioxy-ethylamphetamine (Eve) measured by conditioned place preference in rats. Neurosci Lett 330:280–284

    Article  CAS  PubMed  Google Scholar 

  • Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524–538

    Article  CAS  PubMed  Google Scholar 

  • Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28–39

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Morhenn V, Beavin LE, Zak PJ (2012) Massage increases oxytocin and reduces adrenocorticotropin hormone in humans. Altern Ther Health Med 18:11–18

    PubMed  Google Scholar 

  • Morley KC, McGregor IS (2000) (±)-3, 4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Eur J Pharmacol 408:41–49

    Article  CAS  PubMed  Google Scholar 

  • Neumann ID, Landgraf R (2012) Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci 35:649–659

    Article  CAS  PubMed  Google Scholar 

  • Peartree NA, Hood LE, Thiel KJ, Sanabria F, Pentkowski NS, Chandler KN, Neisewander JL (2012) Limited physical contact through a mesh barrier is sufficient for social reward-conditioned place preference in adolescent male rats. Physiol Behav 105:749–756

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M, McGregor IS (2013) Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3, 4-Methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 38:2249–2259

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rodriguez-Arias M, Valverde O, Daza-Losada M, Blanco-Gandia MC, Aguilar MA, Minarro J (2013) Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 47:77–84

    Article  CAS  Google Scholar 

  • Simmler LD, Hysek CM, Liechti ME (2011) Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab 96:2844–2850

    Article  CAS  PubMed  Google Scholar 

  • Tai K, Zheng X, Narayanan J (2011) Touching a teddy bear mitigates negative effects of social exclusion to increase prosocial behavior. Soc Psychol Personal Sci 2:618–626

    Article  Google Scholar 

  • Thiel KJ, Okun AC, Neisewander JL (2008) Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats. Drug Alcohol Depend 96:202–212

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Thompson M, Callaghan P, Hunt G, Cornish J, McGregor I (2007) A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine ('Ecstasy'). Neuroscience 146:509–514

    Article  CAS  PubMed  Google Scholar 

  • Thompson M, Hunt G, McGregor I (2009) Neural correlates of MDMA ('Ecstasy')-induced social interaction in rats. Soc Neurosci 4:60–72

    Article  CAS  PubMed  Google Scholar 

  • Tops M, Koole SL, IJzerman H, Buisman-Pijlman FT (2013) Why social attachment and oxytocin protect against addiction and stress: insights from the dynamics between ventral and dorsal corticostriatal systems. Pharmacol Biochem Behav 119:39–48

    Article  PubMed  Google Scholar 

  • Toth I, Neumann ID, Slattery DA (2012) Social fear conditioning: a novel and specific animal model to study social anxiety disorder. Neuropsychopharmacology 37:1433–1443

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Trezza V, Damsteegt R, Vanderschuren LJMJ (2009) Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate. Eur Neuropsychopharmacol 19:659–669

  • Tzschentke TM (2007) Review on CPP: measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227–462

    Article  CAS  PubMed  Google Scholar 

  • Uvnas-Moberg K (1998) Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 23:819–835

    Article  CAS  PubMed  Google Scholar 

  • Veenema AH, Bredwold R, De Vries GJ (2011) Vasopressin regulates social recognition in juvenile and adult rats of both sexes, but in sex- and age-specific ways. Horm Behav 61:50–56.

  • Wardle MC, de Wit H (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231:4219–4229

    Article  CAS  PubMed  Google Scholar 

  • Wardle MC, Kirkpatrick MG, de Wit H (2014) 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci 9:1076–1081

    Article  PubMed  Google Scholar 

  • Wilcox RR (1987) New designs in analysis of variance. Annu Rev Psychol 38:29–60

    Article  Google Scholar 

  • Williams JR, Insel TR, Harbaugh CR, Carter CS (1994) Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol 6:247–250

    Article  CAS  PubMed  Google Scholar 

  • Winslow JT (1993) A role for central vasopressin in pair bonding in monogamous prairie voles. Nature 365:545–547

    Article  CAS  PubMed  Google Scholar 

  • Zakharova E, Miller J, Unterwald E, Wade D, Izenwasser S (2009) Social and physical environment alter cocaine conditioned place preference and dopaminergic markers in adolescent male rats. Neuroscience 163:890–897

Download references

Acknowledgments

Research supported by funding from the National Health and Medical Research Council of Australia (NHMRC; project grants 1011518 and 1033444). Linnet Ramos is the recipient of a University of Sydney World Scholars Award. Iain S. McGregor was supported by an Australian Professorial Fellowship from the Australian Research Council and is currently an NHMRC Principal Research Fellow. All animal experiments conducted in this study comply with the Australian code for the care and use of animals for scientific purposes.

Funding and grants

This research was supported by National Health and Medical Research Council grants 1033444 and 1011518.

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iain S. McGregor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramos, L., Hicks, C., Caminer, A. et al. Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats. Psychopharmacology 232, 2631–2641 (2015). https://doi.org/10.1007/s00213-015-3899-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-015-3899-9

Keywords

Navigation